Introduction

Professor Peter Nash and Professor Laura Coates will discuss a recent paper published in R&B Open which is looking at quality of life physical function. The study looked at the impact of an R17-heavened second-kinomab on these and its relation to structural damage in patients with PSA. In this particular paper let's set the scene a little bit. Could you tell the audience about the future five study actually what did they try to do? Yeah, so the future studies were a series of studies looking at the efficacy of the second-kinsomab in psoriatic arthritis as it looks there's quite a few of them.